Raoul Joubran, MD | |
1441 Wilkins Circle, Gastroenterology Associates Pc, Casper, WY 82601 | |
(307) 265-1792 | |
(307) 237-8106 |
Full Name | Raoul Joubran |
---|---|
Gender | Male |
Speciality | Gastroenterology |
Experience | 30 Years |
Location | 1441 Wilkins Circle, Casper, Wyoming |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1689784373 | NPI | - | NPPES |
308745 | Other | WY | BLUE CROSS |
0059279 | Other | MT | MONTANA MEDICAID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 6559A (Wyoming) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Wyoming Medical Center | Casper, WY | Hospital |
Sagewest Health Care | Riverton, WY | Hospital |
Summit Medical Center | Casper, WY | Hospital |
Campbell County Health | Gillette, WY | Hospital |
Memorial Hospital Sweetwater County | Rock springs, WY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Gastroenterology Associates Pc | 8820902695 | 16 |
News Archive
Sleep is a crucial part of human health. Piling up a chronic sleep debt by consistently sleeping less than is needed for a fully rested feeling causes a number of illnesses, including heart disease, cancer and autoimmune conditions.
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
A newer breathing tube could save the lives of more than 10,000 sudden cardiac arrest patients a year for a simple reason: it's easier than standard intubation to insert on the first try, according to researchers from The University of Texas Health Science Center at Houston.
Giving intravenous magnesium to stroke patients soon after the start of symptoms, in an attempt to protect brain cells deprived of oxygen, failed to improve stroke-related disability 3 months later, according to research presented at the American Stroke Association's International Stroke Conference 2014
Santarus, Inc. and Pharming Group NV today announced that the U.S. Food and Drug Administration has accepted for filing the Biologics License Application for the investigational drug RUCONEST (recombinant human C1 esterase inhibitor) 50 IU/kg.
› Verified 1 days ago
Entity Name | Gastroenterology Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811909807 PECOS PAC ID: 8820902695 Enrollment ID: O20031117000116 |
News Archive
Sleep is a crucial part of human health. Piling up a chronic sleep debt by consistently sleeping less than is needed for a fully rested feeling causes a number of illnesses, including heart disease, cancer and autoimmune conditions.
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
A newer breathing tube could save the lives of more than 10,000 sudden cardiac arrest patients a year for a simple reason: it's easier than standard intubation to insert on the first try, according to researchers from The University of Texas Health Science Center at Houston.
Giving intravenous magnesium to stroke patients soon after the start of symptoms, in an attempt to protect brain cells deprived of oxygen, failed to improve stroke-related disability 3 months later, according to research presented at the American Stroke Association's International Stroke Conference 2014
Santarus, Inc. and Pharming Group NV today announced that the U.S. Food and Drug Administration has accepted for filing the Biologics License Application for the investigational drug RUCONEST (recombinant human C1 esterase inhibitor) 50 IU/kg.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Raoul Joubran, MD 1441 Wilkins Circle, Gastroenterology Associates Pc, Casper, WY 82601 Ph: (307) 265-1792 | Raoul Joubran, MD 1441 Wilkins Circle, Gastroenterology Associates Pc, Casper, WY 82601 Ph: (307) 265-1792 |
News Archive
Sleep is a crucial part of human health. Piling up a chronic sleep debt by consistently sleeping less than is needed for a fully rested feeling causes a number of illnesses, including heart disease, cancer and autoimmune conditions.
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
A newer breathing tube could save the lives of more than 10,000 sudden cardiac arrest patients a year for a simple reason: it's easier than standard intubation to insert on the first try, according to researchers from The University of Texas Health Science Center at Houston.
Giving intravenous magnesium to stroke patients soon after the start of symptoms, in an attempt to protect brain cells deprived of oxygen, failed to improve stroke-related disability 3 months later, according to research presented at the American Stroke Association's International Stroke Conference 2014
Santarus, Inc. and Pharming Group NV today announced that the U.S. Food and Drug Administration has accepted for filing the Biologics License Application for the investigational drug RUCONEST (recombinant human C1 esterase inhibitor) 50 IU/kg.
› Verified 1 days ago
Jason Dee Lovell, D.O Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 428 S Durbin St, Ste 104, Casper, WY 82601 Phone: 307-337-4284 Fax: 307-462-0922 | |
Dr. Jonna Wray Cubin, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1233 E 2nd St, Casper, WY 82601 Phone: 307-333-6910 | |
William J. Cobell, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1026 E 2nd St, Casper, WY 82601 Phone: 307-333-0002 Fax: 307-333-4425 | |
Dr. Cory James Stirling, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1300 E A St Ste 104, Casper, WY 82601 Phone: 307-237-1900 Fax: 307-268-8514 | |
Dr. William S Shear, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1026 E 2nd St, Casper, WY 82601 Phone: 307-333-0002 Fax: 307-333-4425 | |
Mr. Henry Kenneth Fisher, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 1230 E 1st St, Casper, WY 82601 Phone: 307-266-3174 Fax: 307-261-6713 | |
Mrs. Vera Lynn Nelson, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 419 S Washington St, Suite 200, Casper, WY 82601 Phone: 307-265-8300 Fax: 307-265-8313 |